Thursday, September 18, 2025
Blogger Facebook Linkedin Pinterest Twitter Youtube

Tag: intranasal semaglutide

Orexo

Orexo’s AmorphOX tech may pave way for intranasal GLP-1 medication

HTP Desk - 0
Orexo AB has announced positive pharmacokinetic in-vivo data for a powder-based intranasal semaglutide formulation developed with the AmorphOX technology. In the in-vivo study, three different...
Healthtekpak delivers daily news, updates, analysis, case studies and industry scoops related to the health industry.
Contact us: editor@ippgroup.in
Blogger Facebook Linkedin Pinterest Twitter Youtube
© 2024 All content (text and/or media) is intellectual property of IPP Catalog Publications Pvt. Ltd.

This function has been disabled for HealthTekPak.

error: Content is protected !!